2011
DOI: 10.1111/j.1365-2141.2011.08706.x
|View full text |Cite
|
Sign up to set email alerts
|

Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk

Abstract: Summary A genome‐wide association study of chronic lymphocytic leukaemia (CLL) suggested that common variants at 15q25.2 (rs783540) and 18q21.1 (rs1036935) influence CLL. To validate these associations and explore their relationship with CLL risk we genotyped case‐control datasets from Poland, UK and Italy totalling 1428 cases and 1920 controls. Combined data from these and previously genotyped series (2503 cases and 5789 controls) provided evidence for an association between 15q25.2 and 18q21.1 loci and CLL r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
20
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 19 publications
(20 citation statements)
references
References 15 publications
0
20
0
Order By: Relevance
“…Recent genome-wide association studies (GWAS) of CLL have provided evidence that the coinheritance of multiple low-risk variants located on chromosomes 2q37.1, 2q37.3, 2q13, 6p21.3, 6p25.3, 8q24.21, 11q24.1, 15q21.3, 15q23, 15q25.2, 16q24.1, and 19q13.32 contributes to the heritability of CLL. [3][4][5][6] The statistical power of individual GWAS has been limited by the modest effect sizes of individual genetic variants, the need to establish stringent statistical significance thresholds, and financial constraints on the number of variants that can be followed up. Meta-analysis of existing GWAS data therefore offers the opportunity to discover additional CLL susceptibility loci.…”
Section: Introductionmentioning
confidence: 99%
“…Recent genome-wide association studies (GWAS) of CLL have provided evidence that the coinheritance of multiple low-risk variants located on chromosomes 2q37.1, 2q37.3, 2q13, 6p21.3, 6p25.3, 8q24.21, 11q24.1, 15q21.3, 15q23, 15q25.2, 16q24.1, and 19q13.32 contributes to the heritability of CLL. [3][4][5][6] The statistical power of individual GWAS has been limited by the modest effect sizes of individual genetic variants, the need to establish stringent statistical significance thresholds, and financial constraints on the number of variants that can be followed up. Meta-analysis of existing GWAS data therefore offers the opportunity to discover additional CLL susceptibility loci.…”
Section: Introductionmentioning
confidence: 99%
“…§African American control RAF were pooled from HapMap data (n ϭ 56-57) and genotypes from African American controls participating in a prostate cancer genome-wide SNP association study (n ϭ 474). 20,21 ʈComparison of RAF from pooled Duke and CRC African American CLL cohorts with pooled African American control CLL RAF.…”
Section: Resultsmentioning
confidence: 99%
“…CLL risk allele frequencies were compared with pooled results from previously published white CLL patients. 9,10,[12][13][14]20,21 Control African American allele frequencies were obtained from published GWA data (474 African American patients from MD Anderson 18,19 ) and from the HapMap database 15 (http://hapmap.ncbi.nlm.nih.gov/). Control allele frequencies were not available for rs1050979.…”
mentioning
confidence: 99%
“…These associations are robust, having been replicated in multiple independent case-control series [46][47][48]. Importantly, none of the genes implicated by these GWAS have previously been evaluated in targeted association studies, emphasising that the candidate gene approach was severely limited by inadequate knowledge of the biology of CLL.…”
Section: Models Of Inherited Predisposition In Cllmentioning
confidence: 93%